These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 20693395

  • 1. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway.
    Li XD, Yang YJ, Geng YJ, Jin C, Hu FH, Zhao JL, Zhang HT, Cheng YT, Qian HY, Wang LL, Zhang BJ, Wu YL.
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1255-61. PubMed ID: 20693395
    [Abstract] [Full Text] [Related]

  • 2. Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.
    Li XD, Yang YJ, Geng YJ, Zhao JL, Zhang HT, Cheng YT, Wu YL.
    Acta Pharmacol Sin; 2012 Jul; 33(7):879-87. PubMed ID: 22659627
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of tongxinluo on endothelin-1 in the mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL, Yang YJ, You SJ, Jin Z, Wu Y, Yang W, Chen J, Gao R, Chen Z.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Oct; 25(10):902-6. PubMed ID: 16313114
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury.
    Qi K, Li L, Li X, Zhao J, Wang Y, You S, Hu F, Zhang H, Cheng Y, Kang S, Cui H, Duan L, Jin C, Zheng Q, Yang Y.
    PLoS One; 2015 Oct; 10(3):e0119846. PubMed ID: 25781461
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.
    Yang C, Talukder MA, Varadharaj S, Velayutham M, Zweier JL.
    Cardiovasc Res; 2013 Jan 01; 97(1):33-43. PubMed ID: 22977010
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation.
    Wang B, Yang Q, Bai WW, Xing YF, Lu XT, Sun YY, Zhao YX.
    PLoS One; 2014 Jan 01; 9(6):e98047. PubMed ID: 24887083
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjöquist PO, Pernow J.
    Cardiovasc Res; 2008 Apr 01; 78(1):116-22. PubMed ID: 18222959
    [Abstract] [Full Text] [Related]

  • 20. Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway.
    Qi K, Li X, Geng Y, Cui H, Jin C, Wang P, Li Y, Yang Y.
    PLoS One; 2018 Apr 01; 13(6):e0198403. PubMed ID: 29912977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.